Nothing is happening and no deal being pursued for k9.
the only game in town is neurological disease and with the flagship being ALS / MND
doing a dog deal could and would jeopardise the price point of the drug for human use… old ground here……………..:
Michael has on several occasions stated the company has the full and only focus as neurological.
when a deal is done, the paying party get everything (buy or licence) and get to choose making it a very clean and very simple transaction
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-429
-
- There are more pages in this discussion • 550 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $50.92K | 290.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 152309 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 329859 | 3 |
View Market Depth
| Last trade - 15.48pm 11/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |